Judith Balmañà
- Oncology top 0.5%
- Molecular Biology top 2%
- Genetics top 0.5%
- Cancer Research top 1%
- Pathology and Forensic Medicine top 0.5%
- Co-authors
- Orland Dı́ezSusan M. DomchekRonnie Shapira‐FrommerBella KaufmanMichael FriedländerGillian MitchellM. William AudehNiklas Loman
- Topics
- BRCA gene mutations in cancer (89 papers)PARP inhibition in cancer therapy (57 papers)Genetic factors in colorectal cancer (47 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Judith Balmañà
171 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 3.9k
- Molecular Biology 2.6k
- Genetics 2.4k
- Cancer Research 1.6k
- Pathology and Forensic Medicine 1.6k
Countries citing papers authored by Judith Balmañà
This map shows the geographic impact of Judith Balmañà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Balmañà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Balmañà more than expected).
Fields of papers citing papers by Judith Balmañà
This network shows the impact of papers produced by Judith Balmañà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Balmañà. The network helps show where Judith Balmañà may publish in the future.
Co-authorship network of co-authors of Judith Balmañà
This figure shows the co-authorship network connecting the top 25 collaborators of Judith Balmañà. A scholar is included among the top collaborators of Judith Balmañà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Balmañà. Judith Balmañà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 1 | |
| 3 | 6 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 0 | |
| 8 | 7 | |
| 9 | A decade of clinical development of PARP inhibitors in perspectivebreakdown → | 495 |
| 10 | 88 | |
| 11 | 12 | |
| 12 | 25 | |
| 13 | 186 | |
| 14 | 21 | |
| 15 | Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screeningbreakdown → | 266 |
| 16 | 336 | |
| 17 | 39 | |
| 18 | 164 | |
| 19 | 29 | |
| 20 | 11 |
About Judith Balmañà
Judith Balmañà is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine, having authored 179 papers that have together received 6.5k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (89 papers), PARP inhibition in cancer therapy (57 papers) and Genetic factors in colorectal cancer (47 papers). The work is most often cited by research in Oncology (3.9k citations), Reproductive Medicine (996 citations) and Cancer Research (1.6k citations). Judith Balmañà has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Orland Dı́ez, Susan M. Domchek, Ronnie Shapira‐Frommer, Bella Kaufman, Michael Friedländer, Gillian Mitchell, M. William Audeh, Niklas Loman, Georgeta Fried and Rita K. Schmutzler. Their work appears in journals such as JAMA, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.